These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16407885)

  • 1. Simvastatin protection against acute immune-mediated glomerulonephritis in mice.
    Christensen M; Su AW; Snyder RW; Greco A; Lipschutz JH; Madaio MP
    Kidney Int; 2006 Feb; 69(3):457-63. PubMed ID: 16407885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
    Rydgren T; Sandler S
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
    Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.
    Oms P; Assie N; Bruniquel F; Degryse AD; van Haverbeke G; Delhon A
    Pharmacol Toxicol; 1995 Dec; 77(6):391-6. PubMed ID: 8835365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
    J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins directly suppress cytokine production in murine intraepithelial lymphocytes.
    Zhang J; Osawa S; Takayanagi Y; Ikuma M; Yamada T; Sugimoto M; Furuta T; Miyajima H; Sugimoto K
    Cytokine; 2013 Feb; 61(2):540-5. PubMed ID: 23290865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats.
    Giusti-Paiva A; Martinez MR; Felix JV; da Rocha MJ; Carnio EC; Elias LL; Antunes-Rodrigues J
    Shock; 2004 Mar; 21(3):271-5. PubMed ID: 14770041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease.
    van Dijk MA; Kamper AM; van Veen S; Souverijn JH; Blauw GJ
    Nephrol Dial Transplant; 2001 Nov; 16(11):2152-7. PubMed ID: 11682660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA.
    Choi M; Rolle S; Rane M; Haller H; Luft FC; Kettritz R
    Kidney Int; 2003 Jan; 63(1):96-106. PubMed ID: 12472772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Simon A; Drewe E; van der Meer JW; Powell RJ; Kelley RI; Stalenhoef AF; Drenth JP
    Clin Pharmacol Ther; 2004 May; 75(5):476-83. PubMed ID: 15116060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination.
    Xiang Z; Reeves SA
    Exp Neurol; 2009 Jan; 215(1):41-7. PubMed ID: 18929563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.